左旋甲状腺素对甲状腺功能减退患者脂代谢的影响

2020-06-08 09:52:15薛松谷丽
中西医结合心血管病电子杂志 2020年2期

薛松 谷丽

【摘要】目的 对甲减患者使用左旋甲状腺素(L-T4)治疗,分析其对脂代谢的影响。方法 选取2015年6月~2019年5月,在我院诊断并治疗的115例甲减患者,将其分为亚临床甲减(SCH)A组35例、亚临床甲减B组40例、临床甲减C组40例,所有患者均使用L-T4治疗。结果 C组患者治疗前总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)水平均明显高于A组,治疗前TC、治疗后TG、LDL-C水平高于B组;与治疗前相比,B组、C组患者的TC水平均显著下降(P<0.05);各组患者不良反应率无明显差异(P>0.05)。结论 对甲减患者使用L-T4治疗可发挥一定降脂效应,血浆促甲状腺激素(TSH)较高亚临床甲减、临床甲减患者脂代谢异常得到改善,TSH较低亚临床甲减患者脂代谢异常无明显改善。

【关键词】甲减;左旋甲状腺素;脂代谢

【中图分类号】R581.2;R589.2 【文献标识码】A 【文章编号】ISSN.2095.6681.2020.2..02

【Abstract】 Objective to analyze the effect of levothyroxine (l-t4) on lipid metabolism in patients with hypothyroidism. Methods 115 cases of hypothyroidism diagnosed and treated in our hospital from June 2015 to May 2019 were selected and divided into 35 cases of subclinical hypothyroidism (SCH) group A, 40 cases of subclinical hypothyroidism group B and 40 cases of clinical hypothyroidism group C. All patients were treated with l-t4. Results the levels of total cholesterol (TC), triglyceride (TG) and low-density lipoprotein (ldl-c) in group C before treatment were significantly higher than those in group A, while the levels of TC before treatment and TG and ldl-c after treatment were significantly higher than those in group B. Compared with before treatment, TC levels in group B and group C were significantly decreased (P < 0.05). There was no significant difference in the rate of adverse reactions in each group (P > 0.05). Conclusion l-t4 treatment for hypothyroidism patients can exert a certain lipid-lowering effect, the plasma thyroid-stimulating hormone (TSH) with high subclinical hypothyroidism, clinical hypothyroidism patients with abnormal lipid metabolism was improved, TSH with low subclinical hypothyroidism patients with abnormal lipid metabolism was not significantly improved.

【Key words】Reduction; Levothyroxine; Lipid metabolism

甲状腺功能减退症(甲减)是一种常见的以全身性低代谢为表现的综合征,主要与甲状腺激素的分泌减少有关。据调查显示,其发病率约为3%~7%,且女性发病率高于男性,且与年龄相关。SCH是指TSH水平升高而游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)水平正常的内分泌代谢性疾病[1]。甲减患者常见的并发症之一就是高脂血症,血脂升高可增加患者心脑血管疾病的危险。因此,为改善患者的中长期预后,必须对患者脂代谢异常的情况进行干预。目前,甲减所致脂代谢异常的机制尚未完全明确,有研究显示[2],促甲状腺激素(TSH)在脂代谢过程中有参与,TSH高表达可能与脂代谢异常有关。本文将对甲减患者使用L-T4治疗,并分析其对脂代谢的影响,现报道如下。……

登录APP查看全文